- Home
- MREO vs ISOU Comparison
MREO vs ISOU Comparison
Compare MREO & ISOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- ISOU
- Stock Information
- Founded
- MREO 2015
- ISOU 2016
- Country
- MREO United Kingdom
- ISOU Canada
- Employees
- MREO N/A
- ISOU N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- ISOU
- Sector
- MREO Health Care
- ISOU
- Exchange
- MREO Nasdaq
- ISOU Nasdaq
- Market Cap
- MREO 438.8M
- ISOU 357.6M
- IPO Year
- MREO N/A
- ISOU N/A
- Fundamental
- Price
- MREO $1.74
- ISOU $7.79
- Analyst Decision
- MREO Strong Buy
- ISOU
- Analyst Count
- MREO 5
- ISOU 0
- Target Price
- MREO $7.20
- ISOU N/A
- AVG Volume (30 Days)
- MREO 1.8M
- ISOU 57.2K
- Earning Date
- MREO 08-12-2025
- ISOU 05-12-2025
- Dividend Yield
- MREO N/A
- ISOU N/A
- EPS Growth
- MREO N/A
- ISOU N/A
- EPS
- MREO N/A
- ISOU N/A
- Revenue
- MREO $500,000.00
- ISOU N/A
- Revenue This Year
- MREO N/A
- ISOU N/A
- Revenue Next Year
- MREO $38.38
- ISOU N/A
- P/E Ratio
- MREO N/A
- ISOU N/A
- Revenue Growth
- MREO N/A
- ISOU N/A
- 52 Week Low
- MREO $1.47
- ISOU $5.72
- 52 Week High
- MREO $5.02
- ISOU $8.64
- Technical
- Relative Strength Index (RSI)
- MREO 44.98
- ISOU N/A
- Support Level
- MREO $1.64
- ISOU N/A
- Resistance Level
- MREO $1.78
- ISOU N/A
- Average True Range (ATR)
- MREO 0.09
- ISOU 0.00
- MACD
- MREO 0.04
- ISOU 0.00
- Stochastic Oscillator
- MREO 87.10
- ISOU 0.00
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About ISOU IsoEnergy Ltd. Common Shares
IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.